Kowa Research Institute
Responsible for clinical development of the parent company's new drug candidates in the United States. Operates U.S. development offices in Morrisville (RTP), NC and Boston, MA. Research focus areas reported by the group include lifestyle-related diseases, immunity/inflammation, sensory organ diseases, and cardiometabolic indications. Engages in clinical development, translational research collaborations, study recruitment, and business development including partnering and licensing.
Industries
Nr. of Employees
small (1-50)
Kowa Research Institute
Services
End-to-end clinical development support for pharmaceutical candidates in the U.S., including trial design, site/investigator coordination, and operations.
Assessment and execution of co-development, co-commercialization, licensing, and partnership opportunities for drug candidates.
Coordination of volunteer and physician inquiries for participation in clinical studies and management of expanded access requests for specific investigational programs.
End-to-end clinical development support for pharmaceutical candidates in the U.S., including trial design, site/investigator coordination, and operations.
Assessment and execution of co-development, co-commercialization, licensing, and partnership opportunities for drug candidates.
Coordination of volunteer and physician inquiries for participation in clinical studies and management of expanded access requests for specific investigational programs.
Expertise Areas
- Clinical trial management
- Multi-regional clinical development (MRCT)
- Cardiometabolic drug development
- Translational research collaborations
Key Technologies
- Clinical trial design
- Multi-regional clinical trials (MRCT)
- Translational research programs
- Study recruitment management